Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 213

1.

Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.

Bernstein ML, Devidas M, Lafreniere D, Souid AK, Meyers PA, Gebhardt M, Stine K, Nicholas R, Perlman EJ, Dubowy R, Wainer IW, Dickman PS, Link MP, Goorin A, Grier HE; Pediatric Oncology Group; Children's Cancer Group Phase II Study 9457; Children's Oncology Group.

J Clin Oncol. 2006 Jan 1;24(1):152-9.

PMID:
16382125
[PubMed - indexed for MEDLINE]
Free Article
2.

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.

Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE.

J Clin Oncol. 2004 Jul 15;22(14):2873-6.

PMID:
15254055
[PubMed - indexed for MEDLINE]
Free Article
3.

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.

Kushner BH, Meyers PA, Gerald WL, Healey JH, La Quaglia MP, Boland P, Wollner N, Casper ES, Aledo A, Heller G, et al.

J Clin Oncol. 1995 Nov;13(11):2796-804.

PMID:
7595741
[PubMed - indexed for MEDLINE]
Free Article
4.

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS.

N Engl J Med. 2003 Feb 20;348(8):694-701.

PMID:
12594313
[PubMed - indexed for MEDLINE]
Free Article
6.

High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.

Milano GM, Cozza R, Ilari I, De Sio L, Boldrini R, Jenkner A, De Ioris M, Inserra A, Dominici C, Donfrancesco A.

Cancer. 2006 Apr 15;106(8):1838-45. Erratum in: Cancer. 2006 Sep 15;107(6):1421.

PMID:
16532434
[PubMed - indexed for MEDLINE]
Free Article
7.

Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.

Saylors RL 3rd, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ; Pediatric Oncology Group.

J Clin Oncol. 2001 Aug 1;19(15):3463-9.

PMID:
11481351
[PubMed - indexed for MEDLINE]
Free Article
8.

A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.

Donaldson SS, Torrey M, Link MP, Glicksman A, Gilula L, Laurie F, Manning J, Neff J, Reinus W, Thompson E, Shuster JJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):125-35.

PMID:
9747829
[PubMed - indexed for MEDLINE]
9.

Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.

Walterhouse DO, Lyden ER, Breitfeld PP, Qualman SJ, Wharam MD, Meyer WH.

J Clin Oncol. 2004 Apr 15;22(8):1398-403. Epub 2004 Mar 8. Erratum in: J Clin Oncol. 2004 Aug 1;22(15):3205.

PMID:
15007087
[PubMed - indexed for MEDLINE]
Free Article
10.

Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.

Oberlin O, Rey A, Desfachelles AS, Philip T, Plantaz D, Schmitt C, Plouvier E, Lejars O, Rubie H, Terrier P, Michon J; Société Française des Cancers de l'Enfant.

J Clin Oncol. 2006 Aug 20;24(24):3997-4002.

PMID:
16921053
[PubMed - indexed for MEDLINE]
Free Article
11.

Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J, Shamberger RC, Goorin A, Miser J, Meyer J, Arndt CA, Sailer S, Marcus K, Perlman E, Dickman P, Grier HE.

J Clin Oncol. 2009 May 20;27(15):2536-41. doi: 10.1200/JCO.2008.19.1478. Epub 2009 Apr 6.

PMID:
19349548
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.

Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, Rausen AR, Robison LL, Vietti TJ, Miser JS.

Blood. 2007 Jan 1;109(1):46-51. Epub 2006 Sep 19.

PMID:
16985182
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.

Craft A, Cotterill S, Malcolm A, Spooner D, Grimer R, Souhami R, Imeson J, Lewis I.

J Clin Oncol. 1998 Nov;16(11):3628-33.

PMID:
9817284
[PubMed - indexed for MEDLINE]
Free Article
14.

Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors.

Hunold A, Weddeling N, Paulussen M, Ranft A, Liebscher C, Jürgens H.

Pediatr Blood Cancer. 2006 Nov;47(6):795-800.

PMID:
16411206
[PubMed - indexed for MEDLINE]
15.

Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.

Blaney SM, Needle MN, Gillespie A, Sato JK, Reaman GH, Berg SL, Adamson PC, Krailo MD, Bleyer WA, Poplack DG, Balis FM.

Clin Cancer Res. 1998 Feb;4(2):357-60.

PMID:
9516923
[PubMed - indexed for MEDLINE]
Free Article
16.

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.

Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS.

Cancer. 2006 Apr 15;106(8):1846-56.

PMID:
16541446
[PubMed - indexed for MEDLINE]
Free Article
17.

Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.

Marina NM, Pappo AS, Parham DM, Cain AM, Rao BN, Poquette CA, Pratt CB, Greenwald C, Meyer WH.

J Clin Oncol. 1999 Jan;17(1):180-90.

PMID:
10458232
[PubMed - indexed for MEDLINE]
Free Article
18.

Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience.

McLean TW, Hertel C, Young ML, Marcus K, Schizer MA, Gebhardt M, Weinstein HJ, Perez-Atayde A, Grier HE.

J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):486-93.

PMID:
10598659
[PubMed - indexed for MEDLINE]
19.

Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.

Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, Bernstein M, Laurie F, Gebhardt MC, Grier HE, Tarbell NJ; Children's Oncology Group.

J Clin Oncol. 2006 Aug 20;24(24):3838-43. Erratum in: J Clin Oncol. 2006 Oct 20;24(30):4947.

PMID:
16921035
[PubMed - indexed for MEDLINE]
Free Article
20.

Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.

Kolb EA, Kushner BH, Gorlick R, Laverdiere C, Healey JH, LaQuaglia MP, Huvos AG, Qin J, Vu HT, Wexler L, Wolden S, Meyers PA.

J Clin Oncol. 2003 Sep 15;21(18):3423-30.

PMID:
12972518
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk